SCHEMBL7419090

SCHEMBL7419090

CCc1c(C(C)=O)c2ccc(C(=O)OC)cc2n1Cc1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.47
MAPT P10636 6/20 0.45
TP53 P04637 2/20 0.45
DPP4 P27487 2/20 0.43
MAPK1 P28482 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 1/20 0.41
S1PR3 Q99500 2/20 0.41
PLA2G2A P14555 1/20 0.41
F2RL3 Q96RI0 3/20 0.40
GAA P10253 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7425821 0.92 L3MBTL1 (0.45) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7474701 0.91 MAPT (0.45) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7468891 0.90 MAPT (0.44) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7467256 0.89 L3MBTL1 (0.49) L3MBTL1TP53DPP4MEN1NPC1
SCHEMBL7422634 0.88 L3MBTL1 (0.42) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7426911 0.88 MAPT (0.47) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7421205 0.88 L3MBTL1 (0.62) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7471798 0.88 L3MBTL1 (0.48) L3MBTL1TP53DPP4LMNAMEN1
SCHEMBL7701998 0.85 MAPT (0.45) L3MBTL1MAPTTP53DPP4MAPK1
SCHEMBL7473116 0.85 MAPT (0.48) L3MBTL1MAPTTP53DPP4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed